Our Mission
Our mission is to improve survival rates in patients with high-risk soft tissue sarcomas
How we will work to achieve our mission
Identify
Our programme aims to identify robust biomarkers that could prospectively stratify patients who are more likely to benefit from therapy before surgery, thereby providing more personalised treatment
Develop
Our programme aims to develop strategies for rational selection of effective therapies and overcome clinical drug resistance to therapy and prevent relapse
Establish
Our programme aims to establish a standardised collection of soft tissue sarcoma clinical and imaging data, to be shared with the sarcoma research community and help improve patient cure rates